2622 Results

People

  1. Reuter
    Reuter
  2. Fong
    Fong
  3. Motzer
    Motzer
  4. Brennan
    Brennan
  5. Akin
    Akin
  6. Eastham
    Eastham
  7. Fine
    Fine
  8. Rusch
    Rusch
  9. Abrey
    Abrey
  10. Gonen
    Gonen

Groups

  1. Department of Medicine (744)
  2. Surgery (660)
  3. Sloan Kettering Institute Faculty (490)
  4. GSK Faculty (474)
  5. Solid Tumor Oncology Division (435)
  6. Survivorship Research (381)
  7. Department of Pathology and Laboratory Medicine (272)
  8. Molecular Pharmacology and Chemistry Program Faculty (271)
  9. Population Sciences Research Program (269)
  10. Radiology, Department of (237)
  1. "2007"
Formats
  1. Journal Article (1654)
  2. Meeting Abstract (774)
  3. Book Section (162)
  4. Conference Paper (22)
  5. Book Whole (10)
Groups
  1. Department of Medicine (744)
  2. Surgery (660)
  3. Sloan Kettering Institute Faculty (490)
  4. GSK Faculty (474)
  5. Solid Tumor Oncology Division (435)
  6. Survivorship Research (381)

More Groups

People
  1. Peter Scardino (58)
  2. Victor Reuter (53)
  3. Yuman Fong (50)
  4. Oguz Akin (48)
  5. Robert Motzer (48)
  6. Murray Brennan (46)

More People

Years
  1. 2007 (2622)
Publications
  1. Journal of Clinical Oncology (228)
  2. Blood (75)
  3. Annals of Surgical Oncology (71)
  4. International Journal of Radiation Oncology, Biology, Physics (61)
  5. Modern Pathology (56)
  6. Laboratory Investigation (53)

More Publications

Publishers
  1. Elsevier Inc. (279)
  2. American Society of Clinical Oncology (229)
  3. Springer (187)
  4. Nature Publishing Group (152)
  5. American Association for Cancer Research (131)
  6. Elsevier Science, Inc. (126)

More Publishers

Results (2622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bevacizumab (Bev) in combination with XELOX or FOLFOX4: Updated efficacy results from XELOX-1/NO16966, a randomized phase III trial in first-line metastatic colorectal cancer
    Meeting Abstract

    Saltz, L.; Clarke, S.; Diaz-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; Koski, S.; Lichinitser, M.; Yang, T.; Cassidy, J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • The Prostate Cancer Clinical Trials Working Group (PCCTWG) consensus criteria for phase II clinical trials for castration-resistant prostate cancer
    Meeting Abstract

    Scher, H. I.; Halabi, S.; Tannock, I.; Morris, M.; Higano, C.; Kelly, W.; Sternberg, C.; Eisenberger, M.; Martin, A.; Hussain, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Volumetric 3D CT analysis - an early predictor of response to therapy
    Meeting Abstract

    Schwartz, L. H.; Curran, S.; Trocola, R.; Randazzo, J.; Ilson, D.; Kelsen, D.; Shah, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A patterns-of-care study of post-progression treatment (Rx) among patients (pts) with advanced pancreas cancer (APC) after gemcitabine therapy on Cancer and Leukemia Group B (CALGB) study #80303
    Meeting Abstract

    Schrag, D.; Archer, L.; Wang, X.; Romanus, D.; Mulcahy, M.; Goldberg, R.; Kindler, H.; for the Cancer and Leukemia Group B (CALGB)
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase II study of preoperative chemotherapy with irinotecan (CPT) and cisplatin (CIS) for gastric cancer (NCI 5917): FDG-PET/CT predicts patient outcome
    Meeting Abstract

    Shah, M. A.; Yeung, H.; Coit, D.; Trocola, R.; Ilson, D.; Randazzo, J.; Tang, L.; Brennan, M.; Divgi, C.; Kelsen, D. P.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A randomized phase II trial comparing pulsed erlotinib before or after carboplatin and paclitaxel in patients with stage IIIB or IV non-small cell lung cancer
    Meeting Abstract

    Riely, G. J.; Rudin, C. M.; Kris, M. G.; Senturk, E.; Azzoli, C. G.; Brahmer, J.; Fogle, M.; Ginsberg, M.; Miller, V. A.; Rizvi, N. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Sunitinib therapy for patients (pts) with metastatic renal cell carcinoma (mRCC): Updated results of two phase II trials and prognostic factor analysis for survival
    Meeting Abstract

    Rosenberg, J. E.; Motzer, R. J.; Michaelson, M. D.; Redman, B. G.; Hudes, G. R.; Bukowski, R. M.; George, D. J.; Kim, S. T.; Baum, C. M.; Wilding, G.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Effect of percutaneous biliary drainage (PBD) for malignant biliary obstruction (MBO) on quality of life (QoL)
    Meeting Abstract

    Robson, P. M.; Heffernan, N.; Holmes, R.; Gonen, M.; Schubert, J.; Getrajdman, G. I.; Brody, L. A.; Brown, K. T.; Covey, A. M.; Blumgart, L. H.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase II trial of extended-dosing temozolomide in patients with melanoma
    Meeting Abstract

    Rietschel, P.; Ejadi, S.; Wolchok, J.; Krown, S.; Gerst, S.; Jungbluth, A.; Busam, K.; Panageas, K.; Smith, K.; Chapman, P.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Minimal residual local disease predicts improved survival after chemoradiotherapy in patients with squamous cell carcinoma of the esophagus
    Meeting Abstract

    Rizk, N. P.; Tang, L.; Park, B. J.; Flores, R.; Venkatraman, E.; Bains, M. S.; Ilson, D.; Minsky, B.; Rusch, V. W.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save